Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVN1000 in Moderate to Severe Acne
NCT01556698Phase 2Completed
- Sponsor
- Novan
- Start
- Jul 2011
- Primary completion
- Dec 2011
- Modality
- Polymer-based Nanoparticles, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of berdazimer in acne vulgaris, sponsored by Novan. Started Jul 2011; status: completed.
02
Drugs
berdazimer
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01556698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01556698.